The effect of virtual reality information videos on anxiety in patients visiting the outpatient clinic of women with abnormal uterine bleeding

ISRCTN ISRCTN18233914
DOI https://doi.org/10.1186/ISRCTN18233914
Secondary identifying numbers N17.053
Submission date
02/04/2021
Registration date
09/04/2021
Last edited
04/05/2021
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Urological and Genital Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English Summary

Background and study aims
Abnormal uterine bleeding (AUB) is bleeding from the uterus that is longer than usual or that occurs at an irregular time. Bleeding may be heavier or lighter than usual and occur often or randomly.
The aim of this study is to investigate whether adding a virtual reality video to the standard information leaflet about the one-stop clinic 'Abnormal uterine bleeding' reduces anxiety.

Who can participate?
Women older than 18 and suffering from abnormal uterine bleeding, referred for a first consultation at the one-stop clinic 'Abnormal Uterine Bleeding' in Máxima MC.

What does the study involve?
Participants are randomly allocated to either the virtual reality group or the control group. The latter only receives the standard information leaflet about the clinic. Women in the VR group receive the standard information leaflet and a virtual reality video about the one-stop clinic.

What are the possible benefits and risks of participating?
Women in the virtual reality group receive additional information about the clinic, which possibly reduces anxiety. There is a small risk of motion sickness during or after watching the VR video.

Where is the study run from?
Máxima Medical Centre Veldhoven (the Netherlands)

When is the study starting and how long is it expected to run for?
November 2016 to September 2017

Who is funding the study?
Máxima Medical Centre Veldhoven (the Netherlands)

Who is the main contact?
Imke Reinders, imke.reinders@maastrichtuniversity.nl

Contact information

Ms Imke Reinders
Scientific

PO Box 7777
Veldhoven
5500 MB
Netherlands

Phone +31 (0)408888380
Email imke.reinders@maastrichtuniversity.nl

Study information

Study designSingle-centre randomized controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typePrevention
Participant information sheet ISRCTN18233914_PIS_in_Dutch.pdf
Scientific titleThe effect of VIrtual Reality information videos on anxiety in patients viSIting the ONe-stop-clinic for women with abnormal uterine bleeding
Study acronymVISION
Study hypothesisAnxiety or distress will be reduced in patients visiting our outpatient clinic for abnormal uterine bleeding by providing patient information through 360˚ virtual reality videos.
Ethics approval(s)On 03/04/2017 the researchers received a statement from their local institutional review board that no ethics approval was required (METC Máxima MC, PO Box 7777, 5500 MB Veldhoven, De Run 4600, 5504 DB Veldhoven, The Netherlands; +31 (0)40 888 95 28; metc@mmc.nl)
ConditionAnxiety prior to visiting a one-stop clinic for women with abnormal uterine bleeding
InterventionPrior to their first visit at the one-stop-clinic for Abnormal Uterine Bleeding, women were informed about this study by telephone. They were not explicitly informed about the role of virtual reality, but that the effect of a new method of patient education was investigated. The women were randomized by computer-generated block randomization. Women in the control group received standard care, which consisted of an information leaflet about the one-stop clinic with a reference to online information on the hospital website. Women in the intervention group received the standard information and were given access to a virtual reality information video about the clinic.
Intervention typeOther
Primary outcome measureAnxiety measured using the visual analogue scale (VAS-anxiety) at baseline (measured before randomization) and in the waiting room before visiting the one-stop clinic
Secondary outcome measures1. Anxiety measured using the visual analoge scale (VAS-anxiety) during the visit (measured directly after the visit)
2. Anxiety measured using the State-Trait Anxiety Inventory (STAI-a) at baseline and in the watiting room
3. Feelings before the visit (feeling prepared, feeling worried, the feeling that better counseling would be helpful) measured on a questionnaire using a 5-point Likert scale in the waiting room.
4. Opinion about the received information about the clinic (completeness, quality, comprehensibility, remembering the information, satisfaction about the information, usefulness of the virtual reality video) measured on a 5-point Likert scale directly after the visit
5. Impression about counselling and anxiety of the women reported by the gynecologist on a 5-point Likert scale, reported at the end of the visit
Overall study start date23/11/2016
Overall study end date21/09/2017

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexFemale
Target number of participants80 women
Total final enrolment88
Participant inclusion criteria1. Every woman suffering from abnormal uterine bleeding, referred for a first consultation at the one-stop clinic 'Abnormal Uterine Bleeding'
2. Women over the age of 18
Participant exclusion criteria1. Poor understanding of the Dutch language
2. Referral to the clinic because of postmenopausal bleeding
3. Referral to the clinic with another reason than abnormal uterine bleeding
Recruitment start date10/04/2017
Recruitment end date11/09/2017

Locations

Countries of recruitment

  • Netherlands

Study participating centre

Máxima Medical Centre
PO box 7777
De Run 4600
Veldhoven
5500 MB
Netherlands

Sponsor information

Máxima Medisch Centrum
Hospital/treatment centre

PO Box 7777
Veldhoven
5500 MB Veldhoven
Netherlands

Phone +31 (0)408888380
Email M.Bongers@mmc.nl
Website https://www.mmc.nl
ROR logo "ROR" https://ror.org/02x6rcb77

Funders

Funder type

Other

Investigor initiated and funded

No information available

Results and Publications

Intention to publish date01/06/2021
Individual participant data (IPD) Intention to shareYes
IPD sharing plan summaryAvailable on request
Publication and dissemination planPlanned publication in a leading peer-reviewed journal.
IPD sharing planThe datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request. The data will be available until 10 years after completion of this trial. All data are anonymized. The reason for viewing data must be mentioned and the researchers will judge if they give insight in (a part of) the dataset

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Participant information sheet 04/05/2021 No Yes
Protocol file 04/05/2021 No No

Additional files

ISRCTN18233914_Protocol_no date.pdf
uploaded 04/05/2021
ISRCTN18233914_PIS_in_Dutch.pdf
uploaded 04/05/2021

Editorial Notes

04/05/2021: The following changes were made to the trial record:
1. Uploaded protocol (not peer-reviewed) as an additional file. Version n/a, no date.
2. The participant information sheet was uploaded as an additional file.
09/04/2021: Trial's existence confirmed by METC Máxima MC